1-150077221-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_007259.5(VPS45):c.566A>G(p.Glu189Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000666 in 1,613,682 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_007259.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000604 AC: 92AN: 152194Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000549 AC: 137AN: 249710Hom.: 0 AF XY: 0.000630 AC XY: 85AN XY: 134954
GnomAD4 exome AF: 0.000672 AC: 982AN: 1461370Hom.: 0 Cov.: 31 AF XY: 0.000675 AC XY: 491AN XY: 726982
GnomAD4 genome AF: 0.000604 AC: 92AN: 152312Hom.: 0 Cov.: 31 AF XY: 0.000510 AC XY: 38AN XY: 74472
ClinVar
Submissions by phenotype
Congenital neutropenia-myelofibrosis-nephromegaly syndrome Uncertain:4
This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 189 of the VPS45 protein (p.Glu189Gly). This variant is present in population databases (rs144659538, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with VPS45-related conditions. ClinVar contains an entry for this variant (Variation ID: 541273). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt VPS45 protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
VPS45 NM_007259.4 exon 6 p.Glu189Gly (c.566A>G): This variant has not been reported in the literature but is present in 0.1% (82/68028) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/1-150077221-A-G?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:541273). Evolutionary conservation suggests that this variant may impact the protein; computational predictive tools for this variant are unclear. Of note, although this variant occurs in the exon, splice prediction tools suggest that this variant may affect splicing. However, further studies are needed to understand its impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
not provided Uncertain:1
BS1_stand-alone -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at